Covance

PPD and Merck in Strategic Outsourcing Deal

Tuesday, January 6, 2009 11:25 AM

Contract research organization (CRO) PPD has entered into a strategic collaboration with Merck that will significantly expand PPD’s global central laboratory business.

More... »


Lowered Guidance Won’t Stop Covance

Monday, January 5, 2009 09:10 AM

Global contract research organization (CRO) Covance ended the year with a flurry, lowering its 2008 guidance, purchasing an equity stake in a proteomics biomarker services provider and adding four executive positions.

More... »


Covance Names New Periapproval Services Executives

Monday, December 29, 2008 11:15 AM

Global contract research organization (CRO) Covance has added three new senior executive positions to its periapproval services team. The Princeton, N.J.-based company appointed Glynis Neagle, M.D., vice president for medical affairs; Robert Bader, director for product safety services; and Thomas Noto, vice president for regulatory affairs.

More... »

Covance Posts 11% Revenue Growth

Thursday, October 23, 2008 04:05 PM

Although Princeton, N.J., CRO Covance experienced a number of third quarter cancellations and project delays, the company posted 11.1% revenue growth for the third quarter. Profit rose 15% to $51.1 million, or $0.80 per diluted share.

More... »

CenterWatch Monthly October 2008

Friday, October 3, 2008 02:44 PM

Trio of Companies in Strategic Outsourcing Partnerships with Lilly

More... »

China-based WuXi Reports Successful Second Quarter

Tuesday, August 19, 2008 11:18 AM

A year after going public on the New York Stock Exchange, Chinese contract research, development and manufacturing company WuXi PharmaTech reported second quarter net revenues of $70.8 million—a 134% increase compared with the same period last year.

More... »

Covance, Lilly Deal Grows on CRO Industry

Friday, August 8, 2008 05:00 PM

Earlier this week, we reported news about the Covance-Lilly $1.6-billion deal, but Clinicaltrialstoday.com has learned additional details about the blockbuster transaction between the contract research organization (CRO) and major pharma company from interviews and Wednesday’s investor conference call.

More... »

Kendle's Global CRO Growth Story Continues with Record Quarter

Thursday, August 7, 2008 07:30 AM

On a day when contract research organization (CRO) Covance announced a blockbuster $1.6 billion deal with Eli Lilly, the global CRO growth story got another big boost when Kendle reported record financial results for its second quarter.

More... »

Covance in Groundbreaking $1.6 Billion Drug Development Services Deal with Eli Lilly

Wednesday, August 6, 2008 09:44 AM

Covance, a leading global contract research organization (CRO), signed a definitive agreement today with Eli Lilly that is designed to help transform Lilly’s R&D model.

More... »

Covance Reports 23% Earnings Growth in 2Q

Thursday, July 31, 2008 09:59 AM

Covance reported after the bell Wednesday that its second quarter earnings jumped 22.7% to 79 cents per diluted share compared with the second quarter of 2007. The contract research organization said the earnings excluded one cent per share gain from the sale of its centralized ECG business in 2007.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs